Jorge Santos da Silva's Insider Trades & SAST Disclosures
Jorge Santos da Silva's most recent trade in MoonLake Immunotherapeutics - Ordinary Shares - Class A was a trade of 95,763 Class A ordinary shares, par value $0.0001 per share done . Disclosure was reported to the exchange on Feb. 27, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jorge Santos da Silva.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MoonLake Immunotherapeutic... | Jorge Santos da Silva | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 95,763 | 3,078,577 | - | 0 | Class A ordinary shares, par value $0.0001 per share | |
| MoonLake Immunotherapeutic... | Jorge Santos da Silva | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 27 Feb 2024 | 62,810 | 3,043,619 | - | 55 | 3,454,550 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Santos da Silva Jorge | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 27 Feb 2024 | 56,065 | 2,987,554 | - | 55 | 3,083,575 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Jorge Santos da Silva | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.89 per share. | 27 Feb 2024 | 4,740 | 2,982,814 | - | 55.9 | 264,919 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Santos da Silva Jorge | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.27 per share. | 21 Feb 2024 | 1,125 | 3,106,429 | - | 55.3 | 62,179 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Jorge Santos da Silva | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 60.18 per share. | 15 Feb 2024 | 20,000 | 3,147,554 | - | 60.2 | 1,203,600 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Jorge Santos da Silva | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 57.44 per share. | 15 Feb 2024 | 20,000 | 3,107,554 | - | 57.4 | 1,148,800 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Santos da Silva Jorge | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 60.15 per share. | 15 Feb 2024 | 20,000 | 3,127,554 | - | 60.2 | 1,203,000 | Class A ordinary shares, par value $0.0001 per share |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges